IRF1 and chronic myelogenous leukemia, BCR-ABL1 positive: Loss of exons 7, 8, and 9 compromises the ability of IRF-1 to heterodimerize with cofactors and/or other IRF members, such as IRF-8, levels of which have also been reported to be reduced in CML patients [78].